BMO Capital analyst Kostas Biliouris upgraded Precision BioSciences Inc. (NASDAQ: DTIL) from Market Perform to Outperform with a price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE